Topics Topics

Phone line to apply for vaccine will start working Wednesday

On Wednesday, February 10, a free phone line 8989 will open to apply for a vaccine against Covid-19, the Ministry of Health said February 8.

The working hours of the phone line will be weekdays from 9:00 to 17:00.

The telephone line should only be used to ensure that the population is registered for the vaccine. Citizens are invited to ask their family doctor for any advice on health issues.

The telephone line is designed to make it easier to apply for those who for objective reasons cannot use the application site www.manavakcina.lv.

When making a call, residents will have to identify themselves with their personal identity number, name and surname,  and indicate their phone number and/or email address, as well as a secondary phone number. 

It is also planned to start vaccination of seniors at the end of February, so it is called on all seniors over the age of 70 to register themselves soon, so that vaccination can be rapidly carried out.

This line is the second of a total of four planned application signup routes. Residents can also  apply on manavakcina.lv, through general practitioners, or through workplace.

Last week, February 5, the application site, www.manavakcina.lv, was launched. By 10.00 on Tuesday, 64 000 people have applied for their vaccine against Covid-19.

None of the application channels has an advantage in planning the vaccination sequence. Whether or not the application will be received on the www.manavakcina.lv website or by phone, at the time the vaccines are available, these data will be used for planning and organizing the vaccination process.

Telephone line work is provided by the 10 customer service operators of the Riga East Clinical University Hospital.

Seen a mistake?

Select text and press Ctrl+Enter to send a suggested correction to the editor

Select text and press Report a mistake to send a suggested correction to the editor

Related articles
Health
Society

Please be aware that the LSM portal uses cookies. By continuing to use this site, you agree that we may store and use cookies on your device. Find out more

Accept and continue